Article
BioNTech mRNA Cancer Vaccine Recruits First Patient Into Phase 2 Trials
Rating:
0.0
Views:
62
Likes:
1
Library:
1
The individualized mRNA cancer vaccine from BioNTech has moved to Phase 2 trials, with a patient from the USA set to receive a doseĀ in the hopes it will pr
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value